Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention

Published:2019-05-01 Issue:3 Volume:31 Page:337-343
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Wang Chenggang¹,Zheng Wen¹,Shaqdan Ayman²,Wang Chunmei¹,Qin Xiuchuan¹,Zhao Xuedong¹,Wang Xu¹,Yuan Lin¹,Nie Shaoping¹,Liu Ran¹

Affiliation:

1. Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China

2. Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, United States

Funder

Capital Health Research and Development of Special Fund

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2019.1609668

Reference22 articles.

1. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

3. Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies

4. A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

5. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitroglycerin plus clopidogrel for acute myocardial infarction and the effect on cardiac function indices;PAK J PHARM SCI;2023

2. Comparative study on the clinical efficacy of clopidogrel and ticagrelor in patients with stent-assisted aneurysm embolization;TROP J PHARM RES;2021

3. Risk Stratification after an Acute Coronary Syndrome: Significance of Antithrombotic Therapy;Journal of Clinical Medicine;2021-04-08

4. Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China;Frontiers in Pharmacology;2021-01-20

5. Noise Resilient Outdoor Traffic Light Visible Light Communications System Based on Logarithmic Transimpedance Circuit: Experimental Demonstration of a 50 m Reliable Link in Direct Sun Exposure;Sensors;2020-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3